Navigation Links
National experts from the John Theurer Cancer Center will present 31 studies at the 2011 ASH Meeting
Date:12/1/2011

BORT): Phase 2 Results, David S. Siegel, MD, PhD, et al.. Oral Session: Dec. 12, 2011 Time: 3:30PM
  • 653 - Myeloma - Therapy, excluding Transplantation: Novel drugs in relapsed/refractory myeloma patients, David S. Siegel, MD PhD, Dec. 12, 2011 Time: 4:30-6:00 PM
  • 811 - Vantage 088: Vorinostat in Combination with Bortezomib in Patients with Relapsed/Refractory Multiple Myeloma: Results of a Global, Randomized Phase 3 Trial, David H. Vesole, MD, PhD, et al.. Oral Session: Dec. 12, 2011 Time: 5:00PM
  • 813 - Final Results From the Bortezomib-nave Group of PX-171-004, a Phase 2 Study of Single-Agent Carfilzomib in Patients with Relapsed and/or Refractory MM, David H. Vesole, MD, PhD, et al... Oral Session: Dec. 12, 2011 Time: 5:00PM
  • 1024 - The Multiple Myeloma Research Consortium (MMRC): Accelerated Start up and Accrual Metrics Speeds Drug Development, David S. Siegel, MD, PhD, et al.. Oral Session: Dec. 13, 2011 Time: 8:15AM
  • 1875 - Unfavorable Cytogenetic Characteristics Do Not Adversely Impact Response Rates in Patients with Relapsed and/or Refractory Multiple Myeloma Treated with Single-Agent Carfilzomib on the 003 (A1) Study, David S. Siegel, MD, PhD, et al.. Poster Session: Dec. 10, 2011 Time: 5:30PM- 7:30PM 8:00PM
  • 1877 - Multivariate Modelling Reveals Evidence of a Dose-Response Relationship in Phase 2 Studies of Single-Agent Carfilzomib, David S. Siegel, MD, PhD, et al.. Poster Session: Dec. 10, 2011 Time: 5:30PM 7:30PM
  • 2877 - Immunoglobulin Free Light Chain (FLC) and Heavy Chain/Light Chain (HLC) Assays Comparison with Electrophoretic Responses in Multiple Myeloma (MM), David H. Vesole, MD, PhD, et al.. Poster Session: Dec. 11, 2011 Time: 6:00PM 8:00PM
  • 2930 - A Phase 1b/2 Study of Prolonged Infusion Carfilzomib in Patients with Relapsed and/or Refractory (R/R) Multiple Myeloma: Updated Efficacy and Tolerability From the Completed 20/56mg/m2 Expansion Cohort of PX-171-007, David H. Vesole, MD, PhD, David S. Siegel, MD, Ph
    '/>"/>

  • Contact: Amy Leahing
    amy.leahing@zibbel.com
    305-458-0599
    John Theurer Cancer Center
    Source:Eurekalert

    Page: 1 2 3 4 5 6 7

    Related biology news :

    1. Registration for the XIX International AIDS Conference (AIDS 2012) opens Dec. 1
    2. Arizona Engineering associate professor earns national recognition
    3. Iowa State engineers establish national panel to advance a carbon negative economy
    4. International team to drill beneath massive Antarctic ice shelf
    5. Story tips from the US Department of Energys Oak Ridge National Laboratory, November 2011
    6. Marine Biological Laboratory Course Director Eric Davidson awarded International Prize for Biology
    7. Veritec and National Identity Solutions (NIS) Sign Significant License Agreement Entering Into a $500 Billion Marketplace
    8. Journal of the Chinese Chemical Society expands international reach with Wiley-VCH
    9. International symposium explores genetic link to mesothelioma and other cancers
    10. Neurotechnology Releases MegaMatcher Accelerator 4.0 for National-scale Fingerprint and Iris Biometric Identification
    11. NOAA releases status on Florida Keys National Marine Sanctuary marine resources
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:4/17/2015)... 17, 2015 Increasing ... technological advancement to drive biometric systems market in ...   According to a recently released ... &  Opportunities, 2020 ", biometric systems market in ... growth at CAGR of over 22% through 2020. ...
    (Date:4/14/2015)... , April 14, 2015 NXT-ID, Inc. ... biometric authentication company focused on the growing mobile commerce ... nominated for the 2015 New York Design Awards under ... Design100, New York City Design Awards are part of ... on over 2,500 ratings from the marketplace, industry and ...
    (Date:4/13/2015)... CHICAGO , April 13, 2015  higi, a ... with ways to more fully engage with their communities ... its industry-leading, privacy protected and secure API.  ... API enables the most accessible, affordable, and convenient vehicle ... The API will ...
    Breaking Biology News(10 mins):Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 2Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 3NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 2NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 3higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 2higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 3
    ... 11, 2010) Advancement in the treatment of cocaine overdoses ... just two examples of the groundbreaking research that will be ... Biotechnology Conference (NBC). The conference takes place Sunday, May 16 ... in San Francisco, Calif. A Possible ...
    ... Arts and Sciences has received a $9.5 million grant ... Cluster in Genome Structure and Developmental Patterning in Health ... such areas as genome structure and stability, developmental and ... to organism" research to advance treatment of hereditary diseases, ...
    ... LA JOLLA, Calif., May 11, 2010 -- Cancer uses ... example is the way tumors express anti-cell death (anti-apoptotic) ... laboratory at Sanford-Burnham Medical Research Institute (Sanford-Burnham) has made ... proteins and make current treatments more effective. In ...
    Cached Biology News:Biotherapeutic Innovations on Display at AAPS National Biotechnology Conference 2Tufts wins NCRR grant for Collaborative Cluster in Genome Structure and Developmental Patterning 2Tufts wins NCRR grant for Collaborative Cluster in Genome Structure and Developmental Patterning 3Cancer: Trapping the escape artist 2
    (Date:5/1/2015)... Albany Molecular Research Inc. (NASDAQ: AMRI ... AMRI,s President and Chief Executive Officer, will present at ... Conference on Wednesday, May 13, 2015 at 4:20 p.m. ... presentation can be accessed at AMRI,s Investor Relations web ... will be archived for 90 days following the live ...
    (Date:4/30/2015)... April 30, 2015  Roka Bioscience, Inc. (NASDAQ: ... advanced testing solutions for the detection of foodborne pathogens, ... first quarter of 2015 on May 7, 2015 after ... Bioscience will also host a conference call at 4:30 ... its first quarter financial results. During the conference call, ...
    (Date:4/30/2015)... (PRWEB) April 30, 2015 Nitto ... today announces its increased capacity and production capability ... increased client variety and service fulfillment continues to ... improve process throughput capacities. , ... newly installed downstream process equipment at its Milford, ...
    (Date:4/30/2015)... , April 30, 2015  The Paul G. Allen ... Investigator (ADI) grants to six groups of researchers with ... challenging roadblocks in neuroscience: growing mature human brain cells ... total of $7.5 million over three years.  ... their research is especially significant because the field of ...
    Breaking Biology Technology:AMRI to Present at the Bank of America Merrill Lynch 2015 Health Care Conference 2Roka Bioscience to Report First Quarter 2015 Financial Results On May 7, 2015 2Biotechnology Manufacturer Nitto Avecia Expands Capacity to Meet Client Demand 2The Paul G. Allen Family Foundation Awards $7.5 Million To Study Brain Cell Growth And Development 2The Paul G. Allen Family Foundation Awards $7.5 Million To Study Brain Cell Growth And Development 3The Paul G. Allen Family Foundation Awards $7.5 Million To Study Brain Cell Growth And Development 4The Paul G. Allen Family Foundation Awards $7.5 Million To Study Brain Cell Growth And Development 5
    ... Universite de Montreal and Validapro Biosciences Inc. have signed an ... standards of the biotherapeutic manufacturing unit located at the Faculty ... veterinary clinical use. , ... Laval, ...
    ... 19 , - Completed ... Opsona Therapeutics, a biotechnology company focused ... diseases, today,announced that Roche Venture Fund and Enterprise Ireland ... financing announced in February,this year, bringing the total round ...
    ... for Mometasone Furoate/Formoterol Combination for Asthma and ... (NYSE: SGP ) today announced ... for the development and commercialization of fixed-dose ... and chronic obstructive pulmonary disease (COPD). ...
    Cached Biology Technology:Roche Venture Fund, Enterprise Ireland Commit EUR3.3 M to Opsona Series B Financing 2Roche Venture Fund, Enterprise Ireland Commit EUR3.3 M to Opsona Series B Financing 3Schering-Plough Announces Changes to its Global Collaboration with Novartis to Develop Combination Therapies for Asthma and COPD 2Schering-Plough Announces Changes to its Global Collaboration with Novartis to Develop Combination Therapies for Asthma and COPD 3Schering-Plough Announces Changes to its Global Collaboration with Novartis to Develop Combination Therapies for Asthma and COPD 4Schering-Plough Announces Changes to its Global Collaboration with Novartis to Develop Combination Therapies for Asthma and COPD 5Schering-Plough Announces Changes to its Global Collaboration with Novartis to Develop Combination Therapies for Asthma and COPD 6Schering-Plough Announces Changes to its Global Collaboration with Novartis to Develop Combination Therapies for Asthma and COPD 7Schering-Plough Announces Changes to its Global Collaboration with Novartis to Develop Combination Therapies for Asthma and COPD 8
    Size & Applications: 100 ul (2 mM). Recommend to use at 1000X dilutions for cell culture (e.g. Add 1 ul to 1 ml of culture medium.) Storage Temp.: -20C Shelf Life: 6-12 month...
    in vitro Translation, Accessory Products...
    Request Info...
    ... The Zero Blunt ... for Sequencing is designed ... sequencing of blunt-end PCR ... provides 5-minute TOPO Cloning ...
    Biology Products: